-
公开(公告)号：US20140197530A1
公开(公告)日：2014-07-17
申请号：US13739045
申请日：2013-01-11
申请人： Thorsten Meyer , Sven Albers , Christian Geissler , Andreas Wolter , Markus Brunnbauer , David O'Sullivan , Frank Zudock , Jan Proschwitz
发明人： Thorsten Meyer , Sven Albers , Christian Geissler , Andreas Wolter , Markus Brunnbauer , David O'Sullivan , Frank Zudock , Jan Proschwitz
CPC分类号： H01L23/315 , H01L21/565 , H01L23/3128 , H01L23/49816 , H01L23/49827 , H01L23/49833 , H01L23/562 , H01L24/19 , H01L2224/02375 , H01L2224/0401 , H01L2224/04105 , H01L2224/12105 , H01L2224/16225 , H01L2224/32225 , H01L2224/73204 , H01L2924/15311 , H01L2924/181 , H01L2924/00012 , H01L2924/00
摘要： A semiconductor device is described having at least one semiconductor chip, the chip having an active area on a top side thereof, the active area formed at least in part of low-k material, said low-k material defining a low-k subarea of said active area; an embedding material, in which said at least one semiconductor chip is embedded, at least part of the embedding material forming a coplanar area with said active area; at least one contact area within the low-k subarea; a redistribution layer on the coplanar area, the redistribution layer connected to said contact areas; at least one first-level interconnect, located outside said low-k subarea, the first-level interconnect electrically connected to at least one of said contact areas via the redistribution layer.
摘要翻译： 描述了半导体器件，其具有至少一个半导体芯片，该芯片在其顶侧具有有源区，至少部分形成在低k材料上的有源区，所述低k材料限定低k分区 说活跃区; 嵌入材料，其中所述至少一个半导体芯片被嵌入，所述嵌入材料的至少一部分与所述有源区域形成共面区域; 低k子区域内的至少一个接触区域; 在共面区域上的再分配层，再分配层连接到所述接触区域; 位于所述低k子区域外的至少一个第一级互连，所述第一级互连经由再分配层电连接到所述接触区域中的至少一个。
-
公开(公告)号：US08314127B2
公开(公告)日：2012-11-20
申请号：US11996133
申请日：2006-07-19
IPC分类号： A61K31/4545 , C07D211/46
CPC分类号： C07C309/73 , C07D211/46
摘要： The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state.
摘要翻译： 本发明提供式（I）的化合物：其中变量在本文中定义; 涉及制备这种化合物的方法; 以及这种化合物在治疗趋化因子（例如CCR3）介导的疾病状态中的用途。
-
公开(公告)号：US20110020284A1
公开(公告)日：2011-01-27
申请号：US12450427
申请日：2008-03-28
申请人： John MacSharry , Liam O'Mahony , David O'Sullivan , Barry Kiely
发明人： John MacSharry , Liam O'Mahony , David O'Sullivan , Barry Kiely
IPC分类号： A61K35/74 , C12N1/21 , C12N1/20 , A61P29/00 , A61P11/06 , A61P37/04 , A61P35/00 , A61P1/12 , A61P25/00 , A61P37/02 , A61P25/28 , A61P19/02 , A61P3/10 , A61P31/04 , A61P31/12 , A61P31/10 , A61P31/18 , A61P35/04 , A61P3/00 , A61P1/04 , A61P37/08 , A61P7/00 , A61P13/12 , A61P9/10 , A61P11/00 , A61P1/16 , A61P19/10 , A61P17/06 , A61P17/10 , A61K39/02
CPC分类号： C12R1/01 , A23L33/135 , A61K35/745 , C12N1/20 , Y02A50/47 , Y02A50/473 , Y02A50/481
摘要： Bifidobacterium strain AH1206 or mutants or variants thereof are immunomodulatory following oral consumption and are useful in the prophylaxis and/or treatment of inflammatory activity for example undesirable gastrointestinal inflammatory activity such as inflammatory bowel disease.
摘要翻译： 双歧杆菌菌株AH1206或其突变体或变体在口服消耗后是免疫调节的，并且可用于预防和/或治疗炎症活性，例如不期望的胃肠炎症活动，例如炎性肠病。
-
公开(公告)号：US07846955B2
公开(公告)日：2010-12-07
申请号：US12523172
申请日：2008-02-06
IPC分类号： A61K31/421 , C07D263/30
CPC分类号： C07D263/32
摘要： The invention provides [2-(4-chloro-benzyloxy)-ethyl]-[2-((R)-cyclohexyl-hydroxy-phenyl-methyl)-oxazol-5-yl-methyl]-dimethyl-ammonium napadisylate, pharmaceutical compositions containing it, and its use in therapy.
摘要翻译： 本发明提供[2-（4-氯 - 苄氧基） - 乙基] - [2 - （（R） - 环己基 - 羟基 - 苯基 - 甲基） - 恶唑-5-基 - 甲基] - 二甲基 - 萘二甲酸铵，药物组合物 含有它，以及其在治疗中的用途。
-
公开(公告)号：US08709398B2
公开(公告)日：2014-04-29
申请号：US12450451
申请日：2008-03-28
申请人： John MacSharry , Liam O'Mahony , David O'Sullivan , Barry Kiely
发明人： John MacSharry , Liam O'Mahony , David O'Sullivan , Barry Kiely
CPC分类号： A61K35/745 , A23L33/135 , A23V2002/00 , C12R1/01 , Y02A50/473
摘要： Probiotic Bifidobacterium strain AH1205 or mutants or variants thereof are immunomodulatory following oral consumption and are useful in the prophylaxis and/or treatment of inflammatory activity such as undesirable gastrointestinal inflammatory activity for example inflammatory bowel disease.
摘要翻译： 益生菌双歧杆菌菌株AH1205或其突变体或变体在口服消耗后是免疫调节的，并且可用于预防和/或治疗炎症活动，例如不期望的胃肠炎症活动，例如炎症性肠病。
-
公开(公告)号：US20130023562A1
公开(公告)日：2013-01-24
申请号：US13560339
申请日：2012-07-27
IPC分类号： C07D211/46 , A61P11/00 , A61P11/06 , A61P19/02 , A61P25/28 , A61P17/06 , A61P17/00 , A61P27/02 , A61P1/04 , A61K31/4545 , A61P19/10
CPC分类号： C07C309/73 , C07D211/46
摘要： The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state.
摘要翻译： 本发明提供式（I）的化合物：其中变量在本文中定义; 涉及制备这种化合物的方法; 以及这种化合物在治疗趋化因子（例如CCR3）介导的疾病状态中的用途。
-
公开(公告)号：US20100093816A1
公开(公告)日：2010-04-15
申请号：US12523172
申请日：2008-02-06
IPC分类号： A61K31/421 , C07D263/30 , A61P11/00
CPC分类号： C07D263/32
摘要： The invention provides [2-(4-chloro-benzyloxy)-ethyl]-[2-((R)-cyclohexyl-hydroxy-phenyl-methyl)-oxazol-5-yl-methyl]-dimethyl-ammonium napadisylate, pharmaceutical compositions containing it, and its use in therapy.
摘要翻译： 本发明提供[2-（4-氯 - 苄氧基） - 乙基] - [2 - （（R） - 环己基 - 羟基 - 苯基 - 甲基） - 恶唑-5-基 - 甲基] - 二甲基 - 萘二甲酸铵，药物组合物 含有它，以及其在治疗中的用途。
-
公开(公告)号：US09473729B2
公开(公告)日：2016-10-18
申请号：US12738830
申请日：2008-10-17
IPC分类号： H04N5/445 , H04N21/482 , H04N21/431 , H04N21/462 , H04N21/485 , H04N21/4147 , H04N21/432 , H04N21/433 , H04N21/472 , H04N21/84 , H04N21/475
CPC分类号： H04N21/47214 , H04N5/445 , H04N5/44543 , H04N21/4147 , H04N21/4312 , H04N21/4316 , H04N21/4325 , H04N21/4334 , H04N21/4335 , H04N21/4622 , H04N21/47217 , H04N21/4753 , H04N21/4755 , H04N21/482 , H04N21/4821 , H04N21/4825 , H04N21/4828 , H04N21/485 , H04N21/84 , H04N2005/44547 , H04N2005/44556 , H04N2005/44565
摘要： Display features of an interactive user interface for a TV environment allow a user to interact with objects and/or information within a display space.
摘要翻译： 显示用于TV环境的交互式用户界面的特征允许用户与显示空间内的对象和/或信息进行交互。
-
公开(公告)号：US09064883B2
公开(公告)日：2015-06-23
申请号：US13218265
申请日：2011-08-25
CPC分类号： H01L21/561 , H01L21/02013 , H01L21/02016 , H01L21/304 , H01L21/311 , H01L21/56 , H01L21/568 , H01L21/6835 , H01L21/78 , H01L23/3107 , H01L23/3121 , H01L23/3135 , H01L23/3157 , H01L23/3185 , H01L24/02 , H01L24/13 , H01L24/19 , H01L24/20 , H01L24/96 , H01L2221/68327 , H01L2223/6677 , H01L2224/0231 , H01L2224/0401 , H01L2224/04105 , H01L2224/05548 , H01L2224/12105 , H01L2224/13022 , H01L2224/73267 , H01L2924/01029 , H01L2924/12042 , H01L2924/1461 , H01L2924/18162 , H01L2924/2064 , H01L2924/00
摘要： A method of manufacturing a device includes providing a semiconductor chip having a first face and a second face opposite to the first face with a contact pad arranged on the first face. The semiconductor chip is placed on a carrier with the first face facing the carrier. The semiconductor chip is encapsulated with an encapsulation material. The carrier is removed and the semiconductor material is removed from the second face of the first semiconductor chip without removing encapsulation material at the same time.
摘要翻译： 一种制造器件的方法包括提供具有第一面和与第一面相对的第二面的半导体芯片，其具有布置在第一面上的接触焊盘。 将半导体芯片放置在载体上，其第一面朝向载体。 半导体芯片用封装材料封装。 移除载体，并且半导体材料从第一半导体芯片的第二面去除，而不会同时去除封装材料。
-
公开(公告)号：US20120207713A1
公开(公告)日：2012-08-16
申请号：US13347289
申请日：2012-01-10
申请人： John MacSharry , Liam O'Mahony , David O'Sullivan , Barry Kiely
发明人： John MacSharry , Liam O'Mahony , David O'Sullivan , Barry Kiely
IPC分类号： A61K35/74 , A61P1/04 , A61P35/00 , A61P37/00 , A61P19/02 , A61P29/00 , A61P1/12 , A61P25/28 , A61P3/10 , A61P31/18 , A61P25/00 , A61P31/04 , A61P31/12 , A61P31/10 , A61P37/06 , A61P11/06 , A61P3/04 , A61P27/14 , A61P35/04 , A61P9/00 , A61P13/12 , A61P1/16 , A61P7/06 , A61P3/02 , A61P19/10 , A61P5/00 , A61P17/02 , A61P17/00 , A61P17/06 , A61P17/10 , A61P37/04 , C12N1/20 , A61P1/02 , A61P13/00 , A61P15/00 , A61P1/00
CPC分类号： A61K35/745 , C12N1/20 , C12R1/01 , Y02A50/473
摘要： Bifidobacterium strain AH1206 or mutants or variants thereof are immunomodulatory following oral consumption and are useful in the prophylaxis and/or treatment of inflammatory activity for example undesirable gastrointestinal inflammatory activity such as inflammatory bowel disease.
摘要翻译： 双歧杆菌菌株AH1206或其突变体或变体在口服消耗后是免疫调节的，并且可用于预防和/或治疗炎症活性，例如不期望的胃肠炎症活动，例如炎性肠病。
-
-
-
-
-
-
-
-
-
搜索结果
18 条记录 (耗时 0.015 秒)
